Contract Manufacturing Services

The COVID-19 pandemic has put additional supply pressures on cold-chain products, such as those encapsulated by LNPs. How can delays be avoided?

We’re moving towards a data-driven future of enhanced manufacturing. And we must lay the foundations today.

As the industry's reliance on CDMOs increases, how can the sector adapt to meet companies' needs?

The small molecule drug development pipeline is booming! And it means new opportunities for CDMOs.

The best machinery can only be made with the input of the people who use it everyday.

From improved supply chains to improved adherence, we explore how smart solutions can transform packaging – and the patient experience.

A collaboration for improved supply chain visibility.

Small molecules continue to play a significant role in the development of innovative treatments.

Here, we speak with Matthew Moorcroft, Vice President of Marketing & Intelligence at Cambrex.

John Fowler, COO at Piramal Pharma Solutions, discusses the challenges CDMOs face in manufacturing ADCs.